https://www.selleckchem.com/products/plx8394.html
The majority of our patients received corticosteroids, tocilizumab, anticoagulation and prone positioning. While higher mortality rates of 30% have been reported in various studies among hospitalized patients with COVID-19, the majority of hospitalized patients in our cohort survived with a low mortality rate. The majority of our patients received corticosteroids, tocilizumab, anticoagulation and prone positioning. While higher mortality rates of 30% have been reported in various studies among hospitalized patients with COVID-19
Like
Comment
Share
